Nzvimbo yechenjedzo yeCampasi yakasvibira: Kune yazvino UMMS campus chenjedzo mamiriro, nhau nezviwanikwa, ndapota shanya umassmed.edu/coronavirus
Sechikamu cheNational Institutes of Health's Rapid Diagnostic Acceleration (RADx) chirongwa, chidzidzo chenguva refu chakanyorwa nevaongorori kubva kuYunivhesiti yeMassachusetts Medical School yakataura kuti PCR bvunzo uye nekukurumidza antigen bvunzo yeSARS-CoV-2 inobatsira pakuona. utachiona Hunoshanda zvakaenzana.Ipa kanenge kaviri pasvondo.
Zvinoenderana nekuburitswa kwenhau yeNIH, kunyangwe kuyerwa kwePCR kunoonekwa seyegoridhe chiyero, inonyanya kunzwisiswa kupfuura kuongororwa kweantigen, kunyanya mumatanho ekutanga ekutapukirwa, asi mhedzisiro inoratidza kuti kana ichiitwa nguva nenguva sechikamu chechirongwa chekuongorora, izvo zviviri. nzira dzekuyedza dzakanyanya kusimba.Kunzwa kunogona kusvika 98%.Idzi inhau dzakanaka dzezvirongwa zvekudzivirira zvakakura, nekuti kuongororwa kweantigen padanho rekutarisira kana kumba kunogona kupa mhedzisiro yekukurumidza pasina kunyorerwa uye haina kudhura pane kuongororwa murabhoritari.
Tsvakurudzo yakabudiswa mu "Journal of Infectious Diseases" musi waJune 30. Vatsvakurudzi vanobva kuYunivhesiti yeI Illinois kuUrbana-Champaign, Johns Hopkins School of Medicine, uye National Institute of Biomedical Imaging uye Bioengineering vakanyora pepa iri ndeiyi: Associate Purofesa. weMishonga Laura L. ·Gibson (Laura L. Gibson);Alyssa N. Owens, Ph.D., Research Coordinator;John P. Broach, MD, MBA, MBA, Mubatsiri Purofesa weEmergency Medicine;Bruce A. Barton, PhD, Population uye Purofesa weQuantitative Health Sciences;Peter Lazar, mugadziri wedhatabhesi rekushandisa;naDavid D. McManus, MD, Richard M. Haidack Purofesa weMishonga, Sachigaro weMishonga uye Purofesa.
Dr. Bruce Tromberg, Director weNIBIB, rimwe divi reNIH, vakati: “Kukurumidza kuyedza antigen kumba kaviri kana katatu pasvondo inzira ine simba uye iri nyore yekuti vanhu vaone hutachiona hweCOVID-19.“Nekuvhurwa kwezvikoro nemabhizinesi, njodzi yekutapukirwa nemunhu inogona kuchinja mazuva ese.Kuenderera mberi nekuongorora maantigen kunogona kubatsira vanhu kubata njodzi iyi uye kuita nekukurumidza kudzivirira kupararira kwehutachiona. "
Vatsvagiri vakaunganidza mafomu maviri emhino nemate samples evashandi nevadzidzi vari kutora chikamu panguva yeCCIDID-19 chirongwa chekuongorora paUniversity yeIllinois kuUrbana-Champaign kwemazuva gumi nemana akateedzana.Imwe yemhino dzemumhino dzemutori wega wega yakatumirwa kuJohns Hopkins University marabhoritari kuona kukura kwehutachiona mhenyu mutsika uye kuyera nguva iyo nyaya inogona kutapurira hutachiona kune vamwe.
Vatsvagiri vacho vakabva vaenzanisa nzira nhatu dzekuona dzeCCIDID-19: mate PCR bvunzo, nasal sampuli PCR bvunzo, uye nasal sampuli yekukurumidza antigen bvunzo.Vakaverenga kunzwisiswa kwenzira yega yega yekuyedza kuona SARS-CoV-2 uye vakayera kuvepo kwehutachiona hwehupenyu mukati memavhiki maviri ehutachiona.
Vatsvagiri pavakaverenga kunzwisiswa kwebvunzo zvichibva pakuyedza rhythm mazuva matatu ega ega, vakashuma kuti kunyangwe vakashandisa kukurumidza antigen bvunzo kana PCR bvunzo, kunzwa kwekuona hutachiona kwakakwira kupfuura 98%.Pavakangoongorora kuwanda kwekuonekwa kamwe chete pasvondo, kunzwisiswa kwePCR yekuona mhino nemate kwakanga kuchiri kwakakwirira, inenge 98%, asi kunzwisiswa kwekuonekwa kweantigen kwakaderera kusvika ku80%.
"Dambudziko mukududzira PCR kana antigen bvunzo mhinduro nderekuti bvunzo yakanaka inogona kusaratidza kuvepo kwehutachiona (yakaderera chaiyo) kana kusaona hutachiona hwepamhepo mumuenzaniso (yakaderera senitivity), zvichiteerana," akadaro mumwe mutungamiri Dr. Gibson.RADx Tech yekiriniki yekutsvaga musimboti.
"Kusarudzika kwekutsvagisa uku ndekwekuti tinobatanidza PCR uye antigen yekuona nehutachiona tsika sechiratidzo chinotapukira.Iyi dhizaini yekutsvagisa inoratidza nzira yakanakisa yekushandisa mhando yega yega yebvunzo, uye inoderedza njodzi yekufungidzirwa COVID-19 Murwere anotsanangura kukanganisa kwekunetsa kwemhedzisiro yavo. "
Dr. Nathaniel Hafer, mubatsiri wepurofesa wemishonga yemamolecular uye mukuru wekuongorora weRADx Tech Study Logistics Core, akati: "Semuenzaniso wekushanda kwebasa redu, data yatinounganidza inobatsira kupa CDC ruzivo pamusoro pevanhu vakasiyana."
Dr. Hafer akataura nezvebasa rinokosha reMass School of Medicine mukugadzira, kushandiswa uye kuongororwa kwechiitiko ichi chekunzwa.Akanyanya kurumbidza timu yekutsvagisa yeYunivhesiti yeMassachusetts Medical School-inotungamirwa naDr. Broach, kusanganisira mutungamiriri wepurojekiti Gul Nowshad uye mufambisi wezvikepe Bernadette Shaw-nebasa ravo rekucherekedza vari kure vatori vechikamu muchidzidzo muimba yekurara Basa rakakosha muYunivhesiti. ye Illinois.
Chirevo chine hukama kubva kuMassMed Nhau: Panguva yekushanya kweCongress kuNIH kambasi, chirongwa cheRADx chakasimbiswa.UMass Medical School inobatsira kutungamira NIH RADx kumhanyisa tekinoroji yekuongorora COVID.Musoro wenhau: UMass Medical Chikoro chinogashira $100 miriyoni NIH mvumo yekusimudzira nekukurumidza, kuwanikwa kweCOVID-100 kuyedzwa.
Questions or comments? Email: UMMSCommunications@umassmed.edu Tel: 508-856-2000 • 508-856-3797 (fax)
Nguva yekutumira: Jul-14-2021